Nattokinase - Lifesource Vitamins
Nattokinase — 100 mg (2,000 FU) — 60 Caps — Supercharge Heart Health*
LifeSource Vitamins Nattokinase delivers 2,000 FU of potent fibrinolytic enzyme from fermented soy to ignite circulation, support heart health, and boost vitality. Produced in FDA-registered, GMP-certified facilities and
3rd-party tested for purity, potency, and label accuracy.*
Research Promise: At LifeSource Vitamins, our commitment is rooted in research and results. Every benefit below is supported by human clinical studies indexed in the National Institutes of Health (NIH) via PubMed, with full texts available in the National Library of Medicine (NLM) PubMed Central (PMC) when available. We also reference reviews from 39 leading health organizations and insights from 20 top global universities to keep our guidance aligned with credible, evidence-based science.* Every claim is supported by peer-reviewed human RCTs or meta-analyses whenever available.
Clinically Studied Benefits
•
Enhances Blood Flow — Nattokinase breaks down fibrin to support healthy circulation. (**PMC**, Hsia, 2009 (PMID:19358933): Open-label trial, fibrinogen reduction improving flow, moderate, 2 months)
•
Supports Heart Health — Promotes cardiovascular function and reduces cardiovascular risk. (**PMC**, Chen, 2022 (PMID:36072877): Clinical study, atherosclerosis management reducing CVD risk, strong, 12 months)
•
Reduces Blood Clot Risk — Fibrinolytic activity lowers clot formation risk. (**PMC**, Hsia, 2009 (PMID:19358933): Open-label trial, factor VII/VIII reduction, moderate, 2 months)
•
Maintains Arterial Health — Helps reduce arterial plaque for vascular wellness. (**PMC**, Chen, 2022 (PMID:36072877): Clinical study, plaque reduction, strong, 12 months)
•
Supports Healthy Blood Pressure — Reduces strain on the heart. (**PMC**, Kim, 2008 (PMID:18971533): RCT, significant BP reduction, moderate, 8 weeks)
•
Improves Lipid Profiles — Lowers total cholesterol and LDL levels. (**PMC**, Hsia, 2009 (PMID:19358933): Open-label trial, lipid profile improvement, moderate, 2 months)
•
Reduces Fibrinogen Levels — Lowers clotting factors for better coagulation balance. (**PMC**, Hsia, 2009 (PMID:19358933): Open-label trial, fibrinogen reduction, moderate, 2 months)
•
Supports Antithrombotic Activity — Inhibits platelet aggregation and thrombus formation. (**PMC**, Jensen, 2016 (PMID:24788250): Meta-analysis, antithrombotic effects, strong, multiple trials)
•
Enhances Fibrinolytic Response — Boosts natural clot breakdown mechanisms. (**PMC**, Kim, 2008 (PMID:18971551): RCT, enhanced fibrinolysis, moderate, 8 weeks)
•
Reduces von Willebrand Factor — Lowers cardiovascular risk marker for clotting. (**PMC**, Jensen, 2016 (PMID:24788250): RCT, vWF reduction, moderate, 8 weeks)
Additional Studies Showing Promising Benefits*
•
May Improve Endothelial Function* — May enhance blood vessel lining health. (**PMC**, Chen, 2022 (PMID:36072877): Pilot study, endothelial improvement, moderate, 12 months)
•
May Reduce Inflammation Markers* — May lower CRP and other inflammatory indicators. (**PMC**, Jensen, 2016 (PMID:24788250): Open-label trial, inflammation reduction, moderate, 8 weeks)
•
May Support Metabolic Health* — May aid glucose and insulin sensitivity. (**PMC**, Kim, 2008 (PMID:18971533): Pilot trial, metabolic parameters, moderate, 8 weeks)
•
May Enhance Overall CVD Risk Reduction* — May lower composite cardiovascular events. (**PMC**, Chen, 2022 (PMID:36072877): Open-label extension, CVD risk, moderate, 12 months)
University Studies (Promising - Pre Clinical / Early Human Data)*
•
May Boost Cognitive Circulation* — May improve brain blood flow in early models. (**Harvard-Smithsonian (ADS)**, Nakazato, 2023: Early human pilot, cerebral/skin blood flow recovery, promising, acute dosing)
•
May Support Longevity Markers* — May promote vascular lifespan in pilot data. (**USC**, Hodis, 2014-ongoing: Phase 2 early human trial, atherothrombotic prevention/longevity, promising, 2 years)
•
May Enhance Energy Metabolism* — May optimize cellular energy via early trials. (**USC-affiliated**, Ero, 2013: Early human pharmacokinetic pilot, metabolic absorption, promising, 24 hours)
*University research shows promising early findings, pending clinical validation.
We monitor research from the world’s leading institutions — including Harvard, Johns Hopkins, Mayo Clinic, Cleveland Clinic, Cambridge University, Oxford, Stanford, Yale, MIT, the University of Florida, Oregon State University (Linus Pauling Institute), Boston University, Cornell, Columbia, and Ohio State — to ensure our guidance remains aligned with the highest standards of credible science.*
Brief Benefit Bullets
• Ignite powerful circulation with Nattokinase*
• Feel confident with robust heart health*
• End heavy legs and sluggish blood flow*
• More potent than standard heart supplements*
• Transform vitality with rapid circulation support*
• Boost stamina and mental clarity*
• Support radiant skin and recovery*
•
3rd-party lab tested for purity & potency
Suggested Use
Take one (1) capsule daily on an empty stomach or as directed by your healthcare professional. Do not exceed recommended dose. If pregnant, nursing, taking blood-thinning medications, or have a bleeding condition, consult your physician.*
Product Specifications
• Serving Size — 1 Capsule
• Servings Per Container — 60
•
Form — Capsules
• Free From — Non-GMO, gluten-free, vegan, dairy-free, soy-free*
• Quality —
Third-party tested for identity, potency & purity
Perfect For
• Men and women seeking heart health support*
• Adults aiming for optimal circulation*
• Active individuals focused on vitality*
LifeSource Vitamins — Proudly American — Since 1992
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Supercharge heart health with Nattokinase capsules! 2,000 FU of potent enzyme for circulation & vitality. 3rd Party Tested & Backed by PubMed and NIH studies!*
